AGTC Joins the My Retina Tracker Program as a New Scientific Collaborator
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), Blueprint Genetics, and Foundation Fighting Blindness, announced that AGTC, a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, will join the My Retina Tracker Program as a new scientific collaborator […]
Using HSV Helper Viruses to Increase AAV Production
Recognizing the industry-wide need to improve adeno-associated virus (AAV) vector manufacturing, UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), has adopted changes intended to increase yield and purity. Some AAV manufacturing processes use adherent cells grown in stacked trays. AGTC sees that model as a barrier to scaling, pointing to the […]
Customized Gene Therapies Successfully Target Rare Eye Diseases
Can gene therapies be effective for the treatment of rare genetic diseases? One company may have found a solution that incorporates a high degree of customization, manufacturing expertise, and years’ worth of knowledge. Having been with Applied Genetic Technologies Corporation (AGTC) for almost 20 years, CEO Sue Washer has first-hand experience in seeing novel ideas […]
AGTC Formalizes Patient Advisory Council to Provide Insights and Guidance on Patient Perspectives for Pipeline Therapies
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company focused on developing adeno-associated virus (AAV) based gene therapies for the treatment of rare inherited diseases, announced the formation of a Patient Advisory Council to build on its focus of incorporating the patient and caregiver voice into […]
AGTC Announces Updated Development Plan for Its X-Linked Retinitis Pigmentosa Clinical Program
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced next steps in the clinical development of the company’s potential treatment of X-linked retinitis pigmentosa (XLRP) caused by mutations in […]
AGTC Boosts AAV Manufacturing Productivity With Herpes Simplex Virus
By using the herpes simplex virus (HSV) as a helper for its adeno-associated viral (AAV) platform UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC) created AAVs that are more robust, purer and lower cost than any of the other methods. Its gene therapy program for X-linked retinitis pigmentosa […]
AGTC Announces Significant Productivity and Quality Enhancement to Its Proprietary Manufacturing Process
UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, provided an update on the continued productivity and quality improvements made in its proprietary manufacturing platform that is currently being used […]
AGTC Launches Nationwide Mobile Vision Testing Program for Patients Enrolled in Its Ongoing Phase 1/2 Clinical Trials
UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced the launch of an innovative mobile vision testing program to conduct follow-up assessments during the COVID-19 pandemic for patients enrolled […]
Otonomy and AGTC Present Preclinical Results for Gene Therapy Hearing Loss Program
Otonomy, Inc., a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, announced preclinical results from the company’s gene therapy collaboration with UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, […]
Foundation Park Building Sells for $12M
Avison Young real estate services announced the sale of a $12 million, newly-constructed 43,180-square-foot biotech and life science research facility at Foundation Park in Alachua. The sale, the largest in Alachua County since 2015 and part of a 1031 exchange, is the first of four buildings that are scheduled to be developed for UF Innovate […]